{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:32:18Z","timestamp":1786735938537,"version":"build-2736575974"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Soc Prevent Communit Dent"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jispcd.jispcd_347_18","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T02:29:30Z","timestamp":1543458570000},"page":"475","source":"Crossref","is-referenced-by-count":1,"title":["Adult immunization \u2013 Need of the hour"],"prefix":"10.4103","volume":"8","author":[{"given":"RahulVinay Chandra","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jairaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Shirisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MuqthadirSiddiqui Mohammad","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamood","family":"Moothedath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2231-0762.246408-1","first-page":"272","volume-title":"Adult immunization-need of the hour","author":"Chakravarthi","year":"2016","journal-title":"J Int Soc Prev Community Dent"},{"key":"key-10.4103\/2231-0762.246408-2","first-page":"63","volume-title":"Anthrax: A continuing problem in Southern India","author":"Lalitha","year":"1996","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/2231-0762.246408-3","first-page":"10","volume-title":"Human anthrax as a re-emerging disease","author":"Doganay","year":"2015","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"key-10.4103\/2231-0762.246408-4","first-page":"456","volume-title":"Anthrax: Where margins are merging between emerging threats and bioterrorism","author":"Banerjee","year":"2017","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2231-0762.246408-5","first-page":"133","volume-title":"Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon","author":"D'Amelio","year":"2015","journal-title":"Environ Int"},{"key":"key-10.4103\/2231-0762.246408-6","first-page":"185","volume-title":"Anthrax pathogenesis","author":"Moayeri","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"key-10.4103\/2231-0762.246408-7","first-page":"815","volume-title":"Anthrax","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-0762.246408-8","doi-asserted-by":"crossref","unstructured":"Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014. doi: 10.3201\/eid2002.130687.","DOI":"10.3201\/eid2002.130687"},{"key":"key-10.4103\/2231-0762.246408-9","first-page":"885","volume-title":"Prophylaxis and treatment of anthrax in pregnant women","author":"Meaney-Delman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/2231-0762.246408-10","first-page":"1","volume-title":"Use of anthrax vaccine in the United States: Recommendations of the advisory committee on immunization practices (ACIP), 2009","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.4103\/2231-0762.246408-11","first-page":"957","volume-title":"Advances in anthrax detection: Overview of bioprobes and biosensors","author":"Kim","year":"2015","journal-title":"Appl Biochem Biotechnol"},{"key":"key-10.4103\/2231-0762.246408-12","first-page":"476","volume-title":"The use of anthrax antigen to immunise man and monkey","author":"Belton","year":"1956","journal-title":"Lancet"},{"key":"key-10.4103\/2231-0762.246408-13","first-page":"28","volume-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","author":"Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"key":"key-10.4103\/2231-0762.246408-14","first-page":"182","volume-title":"Chikungunya fever: A threat to global public health","author":"Moiz\u00e9is","year":"2018","journal-title":"Pathog Glob Health"},{"key":"key-10.4103\/2231-0762.246408-15","first-page":"1231","volume-title":"Chikungunya virus and the global spread of a mosquito-borne disease","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-0762.246408-16","first-page":"S488","volume-title":"Development of vaccines for chikungunya fever","author":"Erasmus","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2231-0762.246408-17","first-page":"213","volume-title":", Ludwig-Begall LF, Oliveira-Filho EF, Oliveira RA, Dur\u00e3es-Carvalho R, Lopes TR, et al. Ascoping review of chikungunya virus infection: Epidemiology, clinical characteristics, viral co-circulation complications, and control","author":"Silva","year":"2018","journal-title":"Acta Trop"},{"key":"key-10.4103\/2231-0762.246408-18","doi-asserted-by":"crossref","unstructured":"Ganesan VK, Duan B, Reid SP. Chikungunya virus: Pathophysiology, mechanism, and modeling. Viruses 2017;9. pii: E368.","DOI":"10.3390\/v9120368"},{"key":"key-10.4103\/2231-0762.246408-19","first-page":"737","volume-title":"Chikungunya virus: Epidemiology, replication, disease mechanisms, and prospective intervention strategies","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2231-0762.246408-20","first-page":"133","volume-title":"Clinical, serological, and virological analysis of 572 chikungunya patients from 2010 to 2013 in India","author":"Jain","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2231-0762.246408-21","first-page":"21","volume-title":"Risk perceptions, attitudes, and knowledge of chikungunya among the public and health professionals: A systematic review","author":"Corrin","year":"2017","journal-title":"Trop Med Health"},{"key":"key-10.4103\/2231-0762.246408-22","first-page":"494","volume-title":"Chikungunya virus: A rheumatologist's perspective","author":"Runowska","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/2231-0762.246408-23","doi-asserted-by":"crossref","unstructured":"Monge P, Vega JM, Sapag AM, Moreno I, Mont\u00fafar R, Khoury V, et al. Pan-American league of associations for rheumatology-central American, Caribbean and Andean Rheumatology Association Consensus-Conference endorsements and recommendations on the diagnosis and treatment of chikungunya-related inflammatory arthropathies in Latin America. J Clin Rheumatol 2018. doi: 10.1097\/RHU.0000000000000868. [Epub ahead of print].","DOI":"10.1097\/RHU.0000000000000868"},{"key":"key-10.4103\/2231-0762.246408-24","doi-asserted-by":"crossref","unstructured":"Dutta SK, Bhattacharya T, Tripathi A. Chikungunya virus: Genomic microevolution in eastern India and its in silico epitope prediction 3 Biotech 2018;8:318.","DOI":"10.1007\/s13205-018-1339-3"},{"key":"key-10.4103\/2231-0762.246408-25","doi-asserted-by":"crossref","unstructured":"Powers AM. Vaccine and therapeutic options to control chikungunya virus. Clin Microbiol Rev 2018;31. pii: e00104-16.","DOI":"10.1128\/CMR.00104-16"},{"key":"key-10.4103\/2231-0762.246408-26","first-page":"25","volume-title":"Chikungunya virus infections: Time to act, time to treat","author":"Abdelnabi","year":"2017","journal-title":"Curr Opin Virol"},{"key":"key-10.4103\/2231-0762.246408-27","doi-asserted-by":"crossref","unstructured":"Subudhi BB, Chattopadhyay S, Mishra P, Kumar A. Current strategies for inhibition of chikungunya infection. Viruses 2018;10. pii: E235.","DOI":"10.3390\/v10050235"},{"key":"key-10.4103\/2231-0762.246408-28","first-page":"2114","volume-title":"Chikungunya: Vaccines and therapeutics","author":"Tharmarajah","year":"1000","journal-title":"F"},{"key":"key-10.4103\/2231-0762.246408-29","first-page":"32","volume-title":"Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against chikungunya virus infection","author":"Jain","year":"2018","journal-title":"Virus disease"},{"key":"key-10.4103\/2231-0762.246408-30","first-page":"3894","volume-title":"Arecombinant virus vaccine that protects against both chikungunya and zika virus infections","author":"Chattopadhyay","year":"2018","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-31","first-page":"1601","volume-title":"In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus","author":"Jain","year":"1000","journal-title":"F"},{"key":"key-10.4103\/2231-0762.246408-32","first-page":"e000530","volume-title":"Zika, chikungunya and dengue: The causes and threats of new and re-emerging arboviral diseases","author":"Paix\u00e3o","year":"2018","journal-title":"BMJ Glob Health"},{"key":"key-10.4103\/2231-0762.246408-33","first-page":"117","volume-title":"Newer vaccines against mosquito-borne diseases","author":"Aggarwal","year":"2018","journal-title":"Indian J Pediatr"},{"key":"key-10.4103\/2231-0762.246408-34","first-page":"4851","volume-title":"Regulatory considerations in development of vaccines to prevent disease caused by chikungunya virus","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-35","first-page":"322","volume-title":"Chikungunya vaccine trials begin","author":"Lyon","year":"2017","journal-title":"JAMA"},{"key":"key-10.4103\/2231-0762.246408-36","first-page":"170","volume-title":"Do we need a vaccine against chikungunya?","author":"Rezza","year":"2015","journal-title":"Pathog Glob Health"},{"key":"key-10.4103\/2231-0762.246408-37","first-page":"2","volume-title":"A quantitative systematic review and meta-analysis of the effectiveness of oral cholera vaccine as a reactive measure in cholera outbreaks","author":"Schwerdtle","year":"2018","journal-title":"Prehosp Disaster Med"},{"key":"key-10.4103\/2231-0762.246408-38","first-page":"1022","volume-title":"Cholera treatment","author":"Blok","year":"1994","journal-title":"Lancet"},{"key":"key-10.4103\/2231-0762.246408-39","first-page":"1080","volume-title":"Protection against cholera from killed whole-cell oral cholera vaccines: A systematic review and meta-analysis","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/2231-0762.246408-40","first-page":"204","volume-title":"Treatment of severe cholera: A review of strategies to reduce stool output and volumes of rehydration fluid","author":"Butler","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/2231-0762.246408-41","first-page":"584","volume-title":"Vaxchora: A Single-dose oral cholera vaccine","author":"Cabrera","year":"2017","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/2231-0762.246408-42","first-page":"197","volume-title":"PaxVax CVD 103-hgR single-dose live oral cholera vaccine","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key-10.4103\/2231-0762.246408-43","first-page":"e0005124","volume-title":"Oral cholera vaccination delivery cost in low- and middle-income countries: An analysis based on systematic review","author":"Mogasale","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2231-0762.246408-44","first-page":"235","volume-title":"Improving immunization approaches to cholera","author":"Saha","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key-10.4103\/2231-0762.246408-45","first-page":"67","volume-title":"Current management of severe dengue infection","author":"Lee","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.4103\/2231-0762.246408-46","first-page":"301","volume-title":"Why are people with dengue dying.A scoping review of determinants for dengue mortality?","author":"Carabali","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/2231-0762.246408-47","first-page":"6803098","volume-title":"Dengue fever: Causes, complications, and vaccine strategies","author":"Khetarpal","year":"2016","journal-title":"J Immunol Res"},{"key":"key-10.4103\/2231-0762.246408-48","first-page":"e0003632","volume-title":"Reviewing dengue: Still a neglected tropical disease?","author":"Horstick","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2231-0762.246408-49","first-page":"3","volume-title":"Dengue vaccines: Challenges, development, current status and prospects","author":"Ghosh","year":"2015","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/2231-0762.246408-50","first-page":"76","volume-title":"Dengue vaccine development: Strategies and challenges","author":"Ramakrishnan","year":"2015","journal-title":"Viral Immunol"},{"key":"key-10.4103\/2231-0762.246408-51","first-page":"212","volume-title":"Tackling dengue fever: Current status and challenges","author":"Nedjadi","year":"2015","journal-title":"Virol J"},{"key":"key-10.4103\/2231-0762.246408-52","first-page":"483","volume-title":"Key concepts, strategies, and challenges in dengue vaccine development: An opportunity for sub-unit candidates?","author":"Lam","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key-10.4103\/2231-0762.246408-53","first-page":"7121","volume-title":"Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine","author":"Precioso","year":"2015","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-54","first-page":"e3306","volume-title":"Approaches to refining estimates of global burden and economics of dengue","author":"Shepard","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2231-0762.246408-55","first-page":"4885","volume-title":"Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials","author":"da","year":"2014","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-56","first-page":"24","volume-title":"The immunogenicity and safety of CYD-tetravalent dengue vaccine (CYD-TDV) in children and adolescents: A systematic review","author":"Agarwal","year":"2017","journal-title":"Acta Med Indones"},{"key":"key-10.4103\/2231-0762.246408-57","first-page":"1059","volume-title":"Vaccines licensed and in clinical trials for the prevention of dengue","author":"Torresi","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.4103\/2231-0762.246408-58","first-page":"165","volume-title":"CYD-TDV dengue vaccine: Systematic review and meta-analysis of efficacy, immunogenicity and safety","author":"God\u00f3i","year":"2017","journal-title":"J Comp Eff Res"},{"key":"key-10.4103\/2231-0762.246408-59","first-page":"757","volume-title":"Influenza in older adults","author":"Talbot","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.4103\/2231-0762.246408-60","first-page":"139","volume-title":"Influenza in children","author":"Kumar","year":"2017","journal-title":"Indian J Pediatr"},{"key":"key-10.4103\/2231-0762.246408-61","first-page":"911","volume-title":"Influenza: A Global perspective","author":"Rotrosen","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"key-10.4103\/2231-0762.246408-62","first-page":"119","volume-title":"Knowns and unknowns of influenza B viruses","author":"Koutsakos","year":"2016","journal-title":"Future Microbiol"},{"key":"key-10.4103\/2231-0762.246408-63","doi-asserted-by":"crossref","unstructured":"Shim JM, Kim J, Tenson T, Min JY, Kainov DE. Influenza virus infection, interferon response, viral counter-response, and apoptosis. Viruses 2017;9. pii: E223.","DOI":"10.3390\/v9080223"},{"key":"key-10.4103\/2231-0762.246408-64","first-page":"123","volume-title":"Household transmission of influenza virus","author":"Tsang","year":"2016","journal-title":"Trends Microbiol"},{"key":"key-10.4103\/2231-0762.246408-65","first-page":"347","volume-title":"Environmental role in influenza virus outbreaks","author":"Sooryanarain","year":"2015","journal-title":"Annu Rev Anim Biosci"},{"key":"key-10.4103\/2231-0762.246408-66","first-page":"891","volume-title":"Health promotion interventions to prevent early childhood human influenza at the household level: A realist review to identify implications for programmes in Hong Kong","author":"Lam","year":"2015","journal-title":"J Clin Nurs"},{"key":"key-10.4103\/2231-0762.246408-67","first-page":"521","volume-title":"Iminosugars: Promising therapeutics for influenza infection","author":"Tyrrell","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"key-10.4103\/2231-0762.246408-68","first-page":"19","volume-title":"Anti-influenza treatment: Drugs currently used and under development","author":"Amarelle","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"key-10.4103\/2231-0762.246408-69","first-page":"545","volume-title":"A trivalent, inactivated influenza vaccine (Vaxigrip\u00ae): Summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries","author":"Haugh","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key-10.4103\/2231-0762.246408-70","first-page":"602","volume-title":"Asystematic review of the comparative epidemiology of avian and human influenza A H5N1 and H7N9 \u2013 Lessons and unanswered questions","author":"Bui","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"key-10.4103\/2231-0762.246408-71","first-page":"521","volume-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-72","first-page":"1104","volume-title":"Improving the selection and development of influenza vaccine viruses \u2013 Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-73","first-page":"254","volume-title":"Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics \u2013 A systematic literature review","author":"Hirve","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.4103\/2231-0762.246408-74","first-page":"6884","volume-title":"Are influenza-associated morbidity and mortality estimates for those \u226565 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?","author":"Thomas","year":"2014","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-75","first-page":"212","volume-title":"Do antibody responses to the influenza vaccine persist year-round in the elderly.A systematic review and meta-analysis?","author":"Young","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-76","first-page":"240","volume-title":"Influenza antivirals currently in late-phase clinical trial","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.4103\/2231-0762.246408-77","first-page":"249","volume-title":"Asystematic review of the health economic consequences of quadrivalent influenza vaccination","author":"de","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"key-10.4103\/2231-0762.246408-78","first-page":"5388","volume-title":"The road to a more effective influenza vaccine: Up to date studies and future prospects","author":"Sano","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-79","first-page":"819","volume-title":"Value for money in H1N1 influenza: A Systematic review of the cost-effectiveness of pandemic interventions","author":"Pasquini-Descomps","year":"2017","journal-title":"Value Health"},{"key":"key-10.4103\/2231-0762.246408-80","first-page":"159","volume-title":"The impact of repeated vaccination on influenza vaccine effectiveness: A systematic review and meta-analysis","author":"Ramsay","year":"2017","journal-title":"BMC Med"},{"key":"key-10.4103\/2231-0762.246408-81","first-page":"154","volume-title":"Public health policy and experience of the 2009 H1N1 influenza pandemic in Pune, India","author":"Purohit","year":"2017","journal-title":"Int J Health Policy Manag"},{"key":"key-10.4103\/2231-0762.246408-82","first-page":"645","volume-title":"Treatment and prevention of pandemic H1N1 influenza","author":"Rewar","year":"2015","journal-title":"Ann Glob Health"},{"key":"key-10.4103\/2231-0762.246408-83","first-page":"h2286","volume-title":"Swine flu: How well did India respond?","author":"D'Silva","year":"2015","journal-title":"BMJ"},{"key":"key-10.4103\/2231-0762.246408-84","first-page":"930","volume-title":"Vaccines against malaria","author":"Ouattara","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2231-0762.246408-85","first-page":"CD008145","volume-title":"Interventions for improving coverage of childhood immunisation in low- and middle-income countries","author":"Oyo-Ita","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2231-0762.246408-86","first-page":"7489","volume-title":"Development of vaccines for Plasmodium vivax malaria","author":"Mueller","year":"2015","journal-title":"Vaccine"},{"key":"key-10.4103\/2231-0762.246408-87","first-page":"717","volume-title":"New insight-guided approaches to detect, cure, prevent and eliminate malaria","author":"Kumar","year":"2015","journal-title":"Protoplasma"},{"key":"key-10.4103\/2231-0762.246408-88","first-page":"4","volume-title":"The clinical development process for a novel preventive vaccine: An overview","author":"Singh","year":"2016","journal-title":"J Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3859","issn-type":"print"},{"key":"key-10.4103\/2231-0762.246408-89","first-page":"261","volume-title":"Development of replication-deficient adenovirus malaria vaccines","author":"Hollingdale","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key-10.4103\/2231-0762.246408-90","first-page":"e13838","volume-title":"Safety, immunogenicity and duration of protection of the RTS, S\/AS02(D) malaria vaccine: One year follow-up of a randomized controlled phase I\/IIb trial","author":"Aide","year":"2010","journal-title":"PLoS One"},{"key":"key-10.4103\/2231-0762.246408-91","first-page":"11","volume-title":"Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS, S\/AS02(D) malaria vaccine in infants living in a malaria-endemic region","author":"Abdulla","year":"2013","journal-title":"Malar J"},{"key":"key-10.4103\/2231-0762.246408-92","first-page":"1359","volume-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","author":"Seder","year":"2013","journal-title":"Science"},{"key":"key-10.4103\/2231-0762.246408-93","first-page":"86","volume-title":"Experience and challenges from clinical trials with malaria vaccines in Africa","author":"Mwangoka","year":"2013","journal-title":"Malar J"}],"container-title":["Journal of International Society of Preventive and Community Dentistry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:35:15Z","timestamp":1786732515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jispcd.JISPCD_347_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"alternative-id":["246408"],"URL":"https:\/\/doi.org\/10.4103\/jispcd.jispcd_347_18","relation":{},"ISSN":["2231-0762"],"issn-type":[{"value":"2231-0762","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}